Status:

UNKNOWN

Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion

Lead Sponsor:

Hartford Hospital

Conditions:

Spine Fusion

Anesthesia, Local

Eligibility:

All Genders

30-80 years

Phase:

PHASE4

Brief Summary

The goal of this clinical trial is to compare two different medications used to reduce pain during lower back fusion surgery. The main questions this study aims to answer are: 1. Can liposomal bupiva...

Detailed Description

The purpose of this study is to improve pain management for patients having spine fusion surgery. This aim will be achieved by evaluating how well liposomal bupivacaine (LB), an FDA approved numbing m...

Eligibility Criteria

Inclusion

  • Lumbar pathology requiring a single or two level elective posterior based (i.e. posterior or transforaminal approach) spine fusion with or without an interbody device.
  • Surgical approach through either a midline or paramedian incision
  • Primary fusion surgery, previous decompression surgery is acceptable
  • American Society of Anesthesiologists (ASA) score of 1,2,or 3.

Exclusion

  • Patients currently on narcotic pain medication for pain management
  • Patients with a history of illicit drug use
  • Patients with neuromuscular disorders or neurological deficits (i.e. post polio or myasthenia gravis)
  • Patients confined to a wheelchair for over 6 months
  • Patients with fibromyalgia or other chronic pain disorder
  • Patient with contraindications for use of the ESP block (i.e. local skin infection over the area of needle entry, or anaphylactic reaction to bupivacaine)
  • Non-invasive surgical approaches
  • Repeat or revision surgery
  • Non-posterior spine surgical approaches (i.e. lateral, oblique, anterior, anterior and posterior approaches)
  • Staged procedures
  • Adjacent segment surgery
  • Patients with a weight less than 40kg to avoid local anesthetic systematic toxicity.

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06107660

Start Date

December 1 2023

End Date

December 1 2025

Last Update

October 30 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.